NTRP NextTrip, Inc.

NASDAQ
$1.67

NextTrip, Inc. (NTRP) is expected to report earnings on October 14, 2026, during market hours. The consensus earnings estimate is a loss of $0.22 per share.

NextTrip Missed Consensus Estimates
Thursday, October 15, 2026 · 4:07 PM ET
Earnings Date
3rd Quarter, Nov 2026
Oct 14
Wednesday · Market Hours
Earnings Whisper
-
vs ($0.22)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.86

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NextTrip, Inc.

Neurotrope Inc is a development stage company. The Company is a clinical stage biopharmaceutical and diagnostics company, engaged in developing drug candidate called bryostatin and a diagnostic test for Alzheimer’s Disease.

Sector

Discretionary

Industry

Leisure & Recreation Services

Charts powered in part by Lightweight Charts™ by TradingView.